Biostar Pharmaceuticals Accounts Payable

Biostar Pharmaceuticals (BSPM) currently reports a accounts payable of $2.7M as of September 2017. That compares with $4.1M in the prior-year period — down 34.4% year over year. Use the charts on this page to explore Biostar Pharmaceuticals's accounts payable history and peer comparisons.

Biostar Pharmaceuticals's accounts payable decreased from $4.1M to $2.7M — a 34.4% year-over-year decrease (period ending September 2017). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biostar Pharmaceuticals reported $2.7M in accounts payable as of September 2017. That compares with $4.1M in the prior-year period — down 34.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $2.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biostar Pharmaceuticals, and consider following BSPM for alerts when major investors trade the stock.